CN106820156A - A kind of probiotic composition of regulating intestinal canal flora health - Google Patents
A kind of probiotic composition of regulating intestinal canal flora health Download PDFInfo
- Publication number
- CN106820156A CN106820156A CN201710086798.XA CN201710086798A CN106820156A CN 106820156 A CN106820156 A CN 106820156A CN 201710086798 A CN201710086798 A CN 201710086798A CN 106820156 A CN106820156 A CN 106820156A
- Authority
- CN
- China
- Prior art keywords
- cfu
- lactobacillus
- bifidobacterium
- parts
- probiotic composition
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000006041 probiotic Substances 0.000 title claims abstract description 38
- 235000018291 probiotics Nutrition 0.000 title claims abstract description 38
- 230000000529 probiotic effect Effects 0.000 title claims abstract description 30
- 239000000203 mixture Substances 0.000 title claims abstract description 24
- 230000036541 health Effects 0.000 title claims description 22
- 230000000968 intestinal effect Effects 0.000 title claims description 19
- 230000001105 regulatory effect Effects 0.000 title claims description 18
- 229940092385 radish extract Drugs 0.000 claims abstract description 20
- 229920001202 Inulin Polymers 0.000 claims abstract description 16
- JYJIGFIDKWBXDU-MNNPPOADSA-N inulin Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)OC[C@]1(OC[C@]2(OC[C@]3(OC[C@]4(OC[C@]5(OC[C@]6(OC[C@]7(OC[C@]8(OC[C@]9(OC[C@]%10(OC[C@]%11(OC[C@]%12(OC[C@]%13(OC[C@]%14(OC[C@]%15(OC[C@]%16(OC[C@]%17(OC[C@]%18(OC[C@]%19(OC[C@]%20(OC[C@]%21(OC[C@]%22(OC[C@]%23(OC[C@]%24(OC[C@]%25(OC[C@]%26(OC[C@]%27(OC[C@]%28(OC[C@]%29(OC[C@]%30(OC[C@]%31(OC[C@]%32(OC[C@]%33(OC[C@]%34(OC[C@]%35(OC[C@]%36(O[C@@H]%37[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O%37)O)[C@H]([C@H](O)[C@@H](CO)O%36)O)[C@H]([C@H](O)[C@@H](CO)O%35)O)[C@H]([C@H](O)[C@@H](CO)O%34)O)[C@H]([C@H](O)[C@@H](CO)O%33)O)[C@H]([C@H](O)[C@@H](CO)O%32)O)[C@H]([C@H](O)[C@@H](CO)O%31)O)[C@H]([C@H](O)[C@@H](CO)O%30)O)[C@H]([C@H](O)[C@@H](CO)O%29)O)[C@H]([C@H](O)[C@@H](CO)O%28)O)[C@H]([C@H](O)[C@@H](CO)O%27)O)[C@H]([C@H](O)[C@@H](CO)O%26)O)[C@H]([C@H](O)[C@@H](CO)O%25)O)[C@H]([C@H](O)[C@@H](CO)O%24)O)[C@H]([C@H](O)[C@@H](CO)O%23)O)[C@H]([C@H](O)[C@@H](CO)O%22)O)[C@H]([C@H](O)[C@@H](CO)O%21)O)[C@H]([C@H](O)[C@@H](CO)O%20)O)[C@H]([C@H](O)[C@@H](CO)O%19)O)[C@H]([C@H](O)[C@@H](CO)O%18)O)[C@H]([C@H](O)[C@@H](CO)O%17)O)[C@H]([C@H](O)[C@@H](CO)O%16)O)[C@H]([C@H](O)[C@@H](CO)O%15)O)[C@H]([C@H](O)[C@@H](CO)O%14)O)[C@H]([C@H](O)[C@@H](CO)O%13)O)[C@H]([C@H](O)[C@@H](CO)O%12)O)[C@H]([C@H](O)[C@@H](CO)O%11)O)[C@H]([C@H](O)[C@@H](CO)O%10)O)[C@H]([C@H](O)[C@@H](CO)O9)O)[C@H]([C@H](O)[C@@H](CO)O8)O)[C@H]([C@H](O)[C@@H](CO)O7)O)[C@H]([C@H](O)[C@@H](CO)O6)O)[C@H]([C@H](O)[C@@H](CO)O5)O)[C@H]([C@H](O)[C@@H](CO)O4)O)[C@H]([C@H](O)[C@@H](CO)O3)O)[C@H]([C@H](O)[C@@H](CO)O2)O)[C@@H](O)[C@H](O)[C@@H](CO)O1 JYJIGFIDKWBXDU-MNNPPOADSA-N 0.000 claims abstract description 16
- 229940029339 inulin Drugs 0.000 claims abstract description 16
- 241000894006 Bacteria Species 0.000 claims abstract description 15
- 108010004032 Bromelains Proteins 0.000 claims abstract description 13
- 239000004365 Protease Substances 0.000 claims abstract description 13
- 235000019835 bromelain Nutrition 0.000 claims abstract description 13
- 241000186016 Bifidobacterium bifidum Species 0.000 claims abstract description 11
- 241001608472 Bifidobacterium longum Species 0.000 claims abstract description 11
- 241000186015 Bifidobacterium longum subsp. infantis Species 0.000 claims abstract description 11
- 240000001046 Lactobacillus acidophilus Species 0.000 claims abstract description 11
- 235000013956 Lactobacillus acidophilus Nutrition 0.000 claims abstract description 11
- 244000199885 Lactobacillus bulgaricus Species 0.000 claims abstract description 11
- 235000013960 Lactobacillus bulgaricus Nutrition 0.000 claims abstract description 11
- 240000006024 Lactobacillus plantarum Species 0.000 claims abstract description 11
- 235000013965 Lactobacillus plantarum Nutrition 0.000 claims abstract description 11
- 241000194020 Streptococcus thermophilus Species 0.000 claims abstract description 11
- 229940002008 bifidobacterium bifidum Drugs 0.000 claims abstract description 11
- 229940004120 bifidobacterium infantis Drugs 0.000 claims abstract description 11
- 229940009291 bifidobacterium longum Drugs 0.000 claims abstract description 11
- 229940039695 lactobacillus acidophilus Drugs 0.000 claims abstract description 11
- 229940004208 lactobacillus bulgaricus Drugs 0.000 claims abstract description 11
- 229940072205 lactobacillus plantarum Drugs 0.000 claims abstract description 11
- 244000199866 Lactobacillus casei Species 0.000 claims abstract description 10
- 235000013958 Lactobacillus casei Nutrition 0.000 claims abstract description 10
- 229940017800 lactobacillus casei Drugs 0.000 claims abstract description 10
- 102000010445 Lactoferrin Human genes 0.000 claims abstract description 8
- 108010063045 Lactoferrin Proteins 0.000 claims abstract description 8
- CSSYQJWUGATIHM-IKGCZBKSSA-N l-phenylalanyl-l-lysyl-l-cysteinyl-l-arginyl-l-arginyl-l-tryptophyl-l-glutaminyl-l-tryptophyl-l-arginyl-l-methionyl-l-lysyl-l-lysyl-l-leucylglycyl-l-alanyl-l-prolyl-l-seryl-l-isoleucyl-l-threonyl-l-cysteinyl-l-valyl-l-arginyl-l-arginyl-l-alanyl-l-phenylal Chemical compound C([C@H](N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CS)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC=1C2=CC=CC=C2NC=1)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC=1C2=CC=CC=C2NC=1)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](C)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CO)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CS)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](C)C(=O)N[C@@H](CC=1C=CC=CC=1)C(O)=O)C1=CC=CC=C1 CSSYQJWUGATIHM-IKGCZBKSSA-N 0.000 claims abstract description 8
- 229940078795 lactoferrin Drugs 0.000 claims abstract description 8
- 235000021242 lactoferrin Nutrition 0.000 claims abstract description 8
- 241000186012 Bifidobacterium breve Species 0.000 claims abstract description 7
- 241000186605 Lactobacillus paracasei Species 0.000 claims abstract description 4
- 229920001542 oligosaccharide Polymers 0.000 claims description 17
- 150000002482 oligosaccharides Chemical class 0.000 claims description 14
- 244000182067 Fraxinus ornus Species 0.000 claims description 8
- 235000002917 Fraxinus ornus Nutrition 0.000 claims description 8
- 235000013351 cheese Nutrition 0.000 claims description 8
- 241000186660 Lactobacillus Species 0.000 claims description 5
- 210000000481 breast Anatomy 0.000 claims description 5
- 229940039696 lactobacillus Drugs 0.000 claims description 5
- 238000005374 membrane filtration Methods 0.000 claims description 5
- 238000002360 preparation method Methods 0.000 claims description 5
- 239000002994 raw material Substances 0.000 claims description 5
- 235000020380 turnip juice Nutrition 0.000 claims description 5
- 229930091371 Fructose Natural products 0.000 claims description 4
- 239000005715 Fructose Substances 0.000 claims description 4
- -1 fructose oligosaccharides Chemical class 0.000 claims description 3
- 230000008901 benefit Effects 0.000 claims description 2
- 238000000034 method Methods 0.000 claims description 2
- 241000193830 Bacillus <bacterium> Species 0.000 claims 1
- 235000011293 Brassica napus Nutrition 0.000 claims 1
- 240000008100 Brassica rapa Species 0.000 claims 1
- 235000000540 Brassica rapa subsp rapa Nutrition 0.000 claims 1
- SHZGCJCMOBCMKK-UHFFFAOYSA-N D-mannomethylose Natural products CC1OC(O)C(O)C(O)C1O SHZGCJCMOBCMKK-UHFFFAOYSA-N 0.000 claims 1
- SHZGCJCMOBCMKK-JFNONXLTSA-N L-rhamnopyranose Chemical compound C[C@@H]1OC(O)[C@H](O)[C@H](O)[C@H]1O SHZGCJCMOBCMKK-JFNONXLTSA-N 0.000 claims 1
- PNNNRSAQSRJVSB-UHFFFAOYSA-N L-rhamnose Natural products CC(O)C(O)C(O)C(O)C=O PNNNRSAQSRJVSB-UHFFFAOYSA-N 0.000 claims 1
- 241000699666 Mus <mouse, genus> Species 0.000 claims 1
- 210000001035 gastrointestinal tract Anatomy 0.000 abstract description 11
- 241000218588 Lactobacillus rhamnosus Species 0.000 abstract description 9
- 230000000694 effects Effects 0.000 abstract description 7
- 230000009286 beneficial effect Effects 0.000 abstract description 5
- 230000003110 anti-inflammatory effect Effects 0.000 abstract 1
- 230000007365 immunoregulation Effects 0.000 abstract 1
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 description 10
- 244000005700 microbiome Species 0.000 description 10
- 229910052742 iron Inorganic materials 0.000 description 5
- 230000000844 anti-bacterial effect Effects 0.000 description 4
- 239000000463 material Substances 0.000 description 4
- 241001465754 Metazoa Species 0.000 description 3
- 230000003115 biocidal effect Effects 0.000 description 3
- 230000033228 biological regulation Effects 0.000 description 3
- 201000010099 disease Diseases 0.000 description 3
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 3
- 235000006694 eating habits Nutrition 0.000 description 3
- 210000000936 intestine Anatomy 0.000 description 3
- 230000000813 microbial effect Effects 0.000 description 3
- 230000002265 prevention Effects 0.000 description 3
- 238000011160 research Methods 0.000 description 3
- 238000002560 therapeutic procedure Methods 0.000 description 3
- 241000186000 Bifidobacterium Species 0.000 description 2
- 102000004190 Enzymes Human genes 0.000 description 2
- 108090000790 Enzymes Proteins 0.000 description 2
- 102000003886 Glycoproteins Human genes 0.000 description 2
- 108090000288 Glycoproteins Proteins 0.000 description 2
- 108091005804 Peptidases Proteins 0.000 description 2
- 102000035195 Peptidases Human genes 0.000 description 2
- 210000001072 colon Anatomy 0.000 description 2
- 238000011161 development Methods 0.000 description 2
- 235000013305 food Nutrition 0.000 description 2
- 238000001727 in vivo Methods 0.000 description 2
- 210000004347 intestinal mucosa Anatomy 0.000 description 2
- 235000013406 prebiotics Nutrition 0.000 description 2
- 244000099147 Ananas comosus Species 0.000 description 1
- 208000017667 Chronic Disease Diseases 0.000 description 1
- 208000035473 Communicable disease Diseases 0.000 description 1
- 206010010356 Congenital anomaly Diseases 0.000 description 1
- 206010010774 Constipation Diseases 0.000 description 1
- 102000015781 Dietary Proteins Human genes 0.000 description 1
- 108010010256 Dietary Proteins Proteins 0.000 description 1
- 241000196324 Embryophyta Species 0.000 description 1
- RFSUNEUAIZKAJO-ARQDHWQXSA-N Fructose Chemical compound OC[C@H]1O[C@](O)(CO)[C@@H](O)[C@@H]1O RFSUNEUAIZKAJO-ARQDHWQXSA-N 0.000 description 1
- 241000282412 Homo Species 0.000 description 1
- 229910019142 PO4 Inorganic materials 0.000 description 1
- 102000003992 Peroxidases Human genes 0.000 description 1
- 229920002472 Starch Polymers 0.000 description 1
- 102000019197 Superoxide Dismutase Human genes 0.000 description 1
- 108010012715 Superoxide dismutase Proteins 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- 230000009471 action Effects 0.000 description 1
- 150000001413 amino acids Chemical class 0.000 description 1
- 230000001093 anti-cancer Effects 0.000 description 1
- 230000002421 anti-septic effect Effects 0.000 description 1
- 239000003963 antioxidant agent Substances 0.000 description 1
- 230000003078 antioxidant effect Effects 0.000 description 1
- 235000006708 antioxidants Nutrition 0.000 description 1
- 230000008827 biological function Effects 0.000 description 1
- 238000009395 breeding Methods 0.000 description 1
- 230000001488 breeding effect Effects 0.000 description 1
- 230000000711 cancerogenic effect Effects 0.000 description 1
- 231100000357 carcinogen Toxicity 0.000 description 1
- 239000003183 carcinogenic agent Substances 0.000 description 1
- 210000004027 cell Anatomy 0.000 description 1
- 229920002678 cellulose Polymers 0.000 description 1
- 239000001913 cellulose Substances 0.000 description 1
- 239000000084 colloidal system Substances 0.000 description 1
- 235000021245 dietary protein Nutrition 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 238000004146 energy storage Methods 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 210000000981 epithelium Anatomy 0.000 description 1
- 230000029142 excretion Effects 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 235000021107 fermented food Nutrition 0.000 description 1
- 150000003278 haem Chemical class 0.000 description 1
- 230000007366 host health Effects 0.000 description 1
- 230000035863 hyperlocomotion Effects 0.000 description 1
- 210000000987 immune system Anatomy 0.000 description 1
- 230000036039 immunity Effects 0.000 description 1
- 230000006698 induction Effects 0.000 description 1
- 108010090785 inulinase Proteins 0.000 description 1
- 210000002429 large intestine Anatomy 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 230000004060 metabolic process Effects 0.000 description 1
- 235000013336 milk Nutrition 0.000 description 1
- 239000008267 milk Substances 0.000 description 1
- 210000004080 milk Anatomy 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 210000004493 neutrocyte Anatomy 0.000 description 1
- 235000016709 nutrition Nutrition 0.000 description 1
- 230000035764 nutrition Effects 0.000 description 1
- 238000011275 oncology therapy Methods 0.000 description 1
- 210000000056 organ Anatomy 0.000 description 1
- 239000002245 particle Substances 0.000 description 1
- 230000008855 peristalsis Effects 0.000 description 1
- 108040007629 peroxidase activity proteins Proteins 0.000 description 1
- 150000002978 peroxides Chemical class 0.000 description 1
- NBIIXXVUZAFLBC-UHFFFAOYSA-K phosphate Chemical compound [O-]P([O-])([O-])=O NBIIXXVUZAFLBC-UHFFFAOYSA-K 0.000 description 1
- 239000010452 phosphate Substances 0.000 description 1
- 108090000765 processed proteins & peptides Proteins 0.000 description 1
- 230000001681 protective effect Effects 0.000 description 1
- 239000008107 starch Substances 0.000 description 1
- 235000019698 starch Nutrition 0.000 description 1
- 238000005303 weighing Methods 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
Abstract
The present invention provide it is a kind of comprising lactoferrin, inulin, bromelain, Radish extract comprehensive probiotic products, rich in the beneficial bacteria of intestinal tract such as lactobacillus acidophilus, bifidobacterium infantis, bifidobacterium longum, bifidobacterium breve, bifidobacterium bifidum, Lactobacillus rhamnosus, lactobacillus bulgaricus, Lactobacillus plantarum, Lactobacillus casei, lactobacillus paracasei, streptococcus thermophilus in the product；And the active principles such as lactoferrin, inulin and bromelain, Radish extract are added in the present invention, and be conducive to colonizing for beneficial bacteria of intestinal tract, it is beneficial to the foundation of healthy gut flora and maintains, the composition also has anti-inflammatory and immunoregulation effect.
Description
Technical field
The invention belongs to fermented food field, and in particular to a kind of probiotic composition of regulating intestinal canal flora health.
Background technology
Gut flora provides nutrition, regulation metabolism, the development of regulation and control gut epithelium and induction congenital immunity, its work(for human body
" organ " that can be important equivalent to the one of human body, the balance for destroying gut flora be exactly the health for damaging people.
Since starting human microbial's group plan HMP from the U.S. in 2008, by a series of big action of microorganism fields,
Current research analyzes the micro organism quantity and structure of 18 positions of the big main region of human body 5 using molecular biology method in the world
Into, Healthy People body surface and the in vivo information of whole microorganism group are almost obtained, find micro- life of the body different parts to living away from home
Thing group have significant effect.The Tiny ecosystem of human body is not only related to infectious diseases, and with the close phase of the development of chronic disease
Close, research of the mankind to Tiny ecosystem changing conventional wisdom of the mankind to disease reason --- cured the disease steering from foeign element
Human body microbial state treatment.
There is a growing awareness that the importance of gut flora microecological balance, probiotics is referred to as microbial food living
Replenishers, it passes through to improve enteric microorganism so as to influence host health.But though viable bacteria content is rich in existing probiotic products
Richness, but microorganism is difficult to be colonized in enteron aisle, so that it improves intestinal microecology effect being limited.Regulation intestines of the present invention
The probiotic composition microorganism group of road flora health into it is abundant, rationally and be collocated with being adapted to inulin that enteric microorganism utilizes,
The prebioticses such as oligosaccharides, and add lactoferrin and bromelain with certain antibacterial action, Radish extract isoreactivity
Material, it is reasonable to be arranged in pairs or groups between each material composition, and considerably increase probiotics colonizes rate, can effectively maintain and/or recover intestines and be good for
The common alimentary canal ecological disturbance problem that health and prevention are caused by pressure, inapt eating habit and antibiotic therapy.
Effect with notable regulating intestinal canal flora health.
The content of the invention
For overcome existing probiotic products probiotics colonize rate it is low so as to cannot the effective healthy problem of regulating intestinal canal flora,
The invention provides a kind of probiotic composition of regulating intestinal canal flora health；The probiotic composition can effectively maintain and/or
Recover gut health and prevention to be lost by the common alimentary canal ecology that pressure, inapt eating habit and antibiotic therapy cause
Tune problem.Effect with notable regulating intestinal canal flora health.
To achieve the above object, the present invention is adopted the following technical scheme that：
A kind of probiotic composition of regulating intestinal canal flora health, including following raw material：Comprehensive probiotics 60-80 parts,
Lactoferrin 0.1-3 parts, inulin 15-20 parts, bromelain 1-3 parts, Radish extract 1-3 parts, oligosaccharides 2-15 parts.
Wherein, the comprehensive probiotic group turns into：Lactobacillus acidophilus, bifidobacterium infantis, bifidobacterium longum, short bifid bar
Bacterium, bifidobacterium bifidum, Lactobacillus rhamnosus, lactobacillus bulgaricus, Lactobacillus plantarum, Lactobacillus casei, secondary cheese breast bar
Bacterium, streptococcus thermophilus.
The oligosaccharides is one or more in manna oligosacchride, manna oligosaccharide, shitosan or fructose oligosaccharides.
The number of viable of the probiotic composition is：Lactobacillus acidophilus 1010-1011CFU/g, bifidobacterium infantis 1010-
1011CFU/g, bifidobacterium longum 109-1010CFU/g, bifidobacterium breve 109-1010CFU/g, bifidobacterium bifidum 109-
1010CFU/g, Lactobacillus rhamnosus 1010-1011CFU/g, lactobacillus bulgaricus 1010-1011CFU/g, Lactobacillus plantarum 1010-
1011CFU/g, Lactobacillus casei 109-1010CFU/g, lactobacillus paracasei 109-1010CFU/g, streptococcus thermophilus 108-
109CFU/g。
The preparation method of the Radish extract is as follows：Broken squeezing, squeezing are carried out after fresh ternip is cleaned into stripping and slicing
During be continuously added the white turnip juice squeezed out, after 0.2 μm of membrane filtration freeze obtain Radish extract.
Lactoferrin：Lactoferrin is a kind of important non-heme combination glycoprotein, neutrophil leucocyte particle in milk
In have bactericidal activity monomeric glycoprotein.Its transhipment for not being only involved in iron, and with broad-spectrum antiseptic, anti-oxidant, anticancer, tune
The section powerful biological function such as immune system, it is considered to be the food of a kind of novel antibacterial, cancer therapy drug and great exploitation potential and
Feed addictive.The dietary proteins source that amino acid is can not only be used in probiotic products is made an addition to, the life of iron is also beneficial to
Thing is utilized.
Inulin：Inulin is the form of another energy storage of the plant in addition to starch, and it is contained in cell with colloid form
In plasm；Inulin can be hydrolyzed into the enzyme for all lacking in fructose, but humans and animals body and decomposing inulin by inulinase.Therefore inulin
Will not be absorbed by human body in vivo, but can be metabolized by human flora after it enters large intestine, research shows, inulin can stimulate enteron aisle
The beneficial bacteriums such as Bifidobacterium are largely bred, and improve Bifidobacterium vigor, suppress cause a disease bacteria growing and breeding, maintain gut flora to put down
Weighing apparatus；Additionally, being that microorganism species and gas production are improved after inulin ferments in colon, so as to promote intestines peristalsis, shorten excrement
In the residence time of colon, make hyperlocomotion, reduce the moisture absorption time, increased stool weight, effective Constipation；
Also increase the excretion of excrement simultaneously, be that the carcinogen in enteron aisle is also diluted.
Bromelain：Bromelain is the proteolytic enzyme being present in pineapple plant, is various different moleculars
The albumen enzyme system group of amount and molecular structure；It also contains phosphate, peroxidase, cellulose in addition to containing protease
Enzyme etc..Animal experiment and human trial show that bromelain is absorbed profit with 40% ratio in animal intestinal tract with prototype
With.Further, since there is biologically active peptide in bromelain, therefore it can suppress the growth of human body bacterium.
Radish extract：Radish extract can improve superoxide dismutase activity, reduce mda content and can
The peroxide for repairing intestinal mucosa is damaged, and has protective effect to intestinal mucosa.
The advantage of the invention is that：The probiotic composition microorganism group of regulating intestinal canal flora of the present invention health into
It is abundant, rationally and be collocated with being adapted to the prebioticses such as inulin, oligosaccharides that enteric microorganism utilizes, and add and make with certain antibacterial
Lactoferrin and bromelain, Radish extract isoreactivity material, it is reasonable to be arranged in pairs or groups between each material composition, increases greatly
Added probiotics colonizes rate, can effectively maintain and/or recover gut health and prevention by pressure, inapt eating habit and
The common alimentary canal ecological disturbance problem that antibiotic therapy causes.Effect with notable regulating intestinal canal flora health.
Specific embodiment
Embodiment 1
A kind of probiotic composition of regulating intestinal canal flora health, including following raw material：68 parts of comprehensive probiotics, newborn iron
2 parts of albumen, 18 parts of inulin, 2 parts of bromelain, 2 parts of Radish extract, 8 parts of oligosaccharides.
Wherein, the comprehensive probiotic group turns into：Lactobacillus acidophilus, bifidobacterium infantis, bifidobacterium longum, short bifid bar
Bacterium, bifidobacterium bifidum, Lactobacillus rhamnosus, lactobacillus bulgaricus, Lactobacillus plantarum, Lactobacillus casei, secondary cheese breast bar
Bacterium, streptococcus thermophilus.
The oligosaccharides is manna oligosacchride.
The number of viable of the probiotic composition is：Lactobacillus acidophilus 1011CFU/g, bifidobacterium infantis 1011CFU/
G, bifidobacterium longum 1010CFU/g, bifidobacterium breve 1010CFU/g, bifidobacterium bifidum 1010CFU/g, Lactobacillus rhamnosus
1011CFU/g, lactobacillus bulgaricus 1011CFU/g, Lactobacillus plantarum 1011CFU/g, Lactobacillus casei 1010CFU/g, secondary cheese
Lactobacillus 1010CFU/g, streptococcus thermophilus 109CFU/g。
The preparation method of the Radish extract is as follows：Broken squeezing, squeezing are carried out after fresh ternip is cleaned into stripping and slicing
During be continuously added the white turnip juice squeezed out, after 0.2 μm of membrane filtration freeze obtain Radish extract.
Embodiment 2
A kind of probiotic composition of regulating intestinal canal flora health, including following raw material：60 parts of comprehensive probiotics, newborn iron
3 parts of albumen, 20 parts of inulin, 3 parts of bromelain, 3 parts of Radish extract, 11 parts of oligosaccharides.
Wherein, the comprehensive probiotic group turns into：Lactobacillus acidophilus, bifidobacterium infantis, bifidobacterium longum, short bifid bar
Bacterium, bifidobacterium bifidum, Lactobacillus rhamnosus, lactobacillus bulgaricus, Lactobacillus plantarum, Lactobacillus casei, secondary cheese breast bar
Bacterium, streptococcus thermophilus.
The oligosaccharides is manna oligosacchride, manna oligosaccharide, shitosan and each 2 parts of fructose oligosaccharides.
The number of viable of the probiotic composition is：Lactobacillus acidophilus 1010CFU/g, bifidobacterium infantis 1010CFU/
G, bifidobacterium longum 109CFU/g, bifidobacterium breve 109CFU/g, bifidobacterium bifidum 109CFU/g, Lactobacillus rhamnosus
1010CFU/g, lactobacillus bulgaricus 1010CFU/g, Lactobacillus plantarum 1010CFU/g, Lactobacillus casei 109CFU/g, secondary cheese
Lactobacillus 109CFU/g, streptococcus thermophilus 108CFU/g。
The preparation method of the Radish extract is as follows：Broken squeezing, squeezing are carried out after fresh ternip is cleaned into stripping and slicing
During be continuously added the white turnip juice squeezed out, after 0.2 μm of membrane filtration freeze obtain Radish extract.
Embodiment 3
A kind of probiotic composition of regulating intestinal canal flora health, including following raw material：80 parts of comprehensive probiotics, newborn iron
0.1 part of albumen, 15 parts of inulin, 1 part of bromelain, 1 part of Radish extract, 2.9 parts of oligosaccharides.
Wherein, the comprehensive probiotic group turns into：Lactobacillus acidophilus, bifidobacterium infantis, bifidobacterium longum, short bifid bar
Bacterium, bifidobacterium bifidum, Lactobacillus rhamnosus, lactobacillus bulgaricus, Lactobacillus plantarum, Lactobacillus casei, secondary cheese breast bar
Bacterium, streptococcus thermophilus.
The oligosaccharides is manna oligosacchride and each 1.45 parts of shitosan.
The number of viable of the probiotic composition is：Lactobacillus acidophilus 1011CFU/g, bifidobacterium infantis 1010CFU/
G, bifidobacterium longum 109CFU/g, bifidobacterium breve 109CFU/g, bifidobacterium bifidum 109CFU/g, Lactobacillus rhamnosus
1011CFU/g, lactobacillus bulgaricus 1011CFU/g, Lactobacillus plantarum 1011CFU/g, Lactobacillus casei 1010CFU/g, secondary cheese
Lactobacillus 109CFU/g, streptococcus thermophilus 109CFU/g。
The preparation method of the Radish extract is as follows：Broken squeezing, squeezing are carried out after fresh ternip is cleaned into stripping and slicing
During be continuously added the white turnip juice squeezed out, after 0.2 μm of membrane filtration freeze obtain Radish extract.
The foregoing is only presently preferred embodiments of the present invention, all impartial changes done according to scope of the present invention patent with
Modification, should all belong to covering scope of the invention.
Claims (5)
1. the probiotic composition of a kind of regulating intestinal canal flora health, it is characterised in that：Including following raw material：Comprehensive benefit
Raw bacterium 60-80 parts, lactoferrin 0.1-3 parts, inulin 15-20 parts, bromelain 1-3 parts, Radish extract 1-3 parts, oligosaccharides
2-15 parts.
2. the probiotic composition of a kind of regulating intestinal canal flora health according to claim 1, it is characterised in that：It is described comprehensive
Closing probiotic group turns into：Lactobacillus acidophilus, bifidobacterium infantis, bifidobacterium longum, bifidobacterium breve, bifidobacterium bifidum, mouse
Lee's sugar lactobacillus, lactobacillus bulgaricus, Lactobacillus plantarum, Lactobacillus casei, lactobacillus paracasei, streptococcus thermophilus.
3. a kind of probiotic composition of regulating intestinal canal flora health according to claim 1, it is characterised in that the widow
Sugar is one or more in manna oligosacchride, manna oligosaccharide, shitosan or fructose oligosaccharides.
4. a kind of probiotic composition of regulating intestinal canal flora health according to claim 1 and 2, it is characterised in that institute
The number of viable for stating probiotic composition is：Lactobacillus acidophilus 1010-1011CFU/g, bifidobacterium infantis 1010-1011CFU/g、
Bifidobacterium longum 109-1010CFU/g, bifidobacterium breve 109-1010CFU/g, bifidobacterium bifidum 109-1010CFU/g, rhamnose
Lactobacillus 1010-1011CFU/g, lactobacillus bulgaricus 1010-1011CFU/g, Lactobacillus plantarum 1010-1011CFU/g, cheese breast
Bacillus 109-1010CFU/g, lactobacillus paracasei 109-1010CFU/g, streptococcus thermophilus 108-109CFU/g。
5. the probiotic composition of a kind of regulating intestinal canal flora health according to claim 1, it is characterised in that described white
The preparation method of Turnip extractive is as follows：Broken squeezing is carried out after fresh ternip is cleaned into stripping and slicing, is continuously added in expressing process
The white turnip juice squeezed out, freezes after 0.2 μm of membrane filtration and obtains Radish extract.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201710086798.XA CN106820156A (en) | 2017-02-17 | 2017-02-17 | A kind of probiotic composition of regulating intestinal canal flora health |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201710086798.XA CN106820156A (en) | 2017-02-17 | 2017-02-17 | A kind of probiotic composition of regulating intestinal canal flora health |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN106820156A true CN106820156A (en) | 2017-06-13 |
Family
ID=59127801
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201710086798.XA Pending CN106820156A (en) | 2017-02-17 | 2017-02-17 | A kind of probiotic composition of regulating intestinal canal flora health |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN106820156A (en) |
Cited By (18)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN107455744A (en) * | 2017-08-22 | 2017-12-12 | 绵阳市润土农业科技开发有限公司 | A kind of fementative composition ferment and preparation method thereof in vivo |
| CN108208843A (en) * | 2017-12-30 | 2018-06-29 | 广州润虹医药科技股份有限公司 | A kind of health composition for adjusting intestinal flora and application thereof |
| CN108936679A (en) * | 2018-08-29 | 2018-12-07 | 广东时代食品与生命健康研究有限公司 | A kind of compound intestinal health health care product |
| CN109123679A (en) * | 2018-08-21 | 2019-01-04 | 卓源健康科技有限公司 | A kind of lactic bacteria composition and preparation method thereof with adjusting intestinal flora function |
| CN109432333A (en) * | 2018-10-11 | 2019-03-08 | 张军毅 | A kind of synbiotic compound preparation and preparation method thereof for helping to alleviate no solid lesion hypertension symptom |
| WO2019049157A1 (en) * | 2017-09-10 | 2019-03-14 | Technion Research & Development Foundation Limited | Composition and method for a prebiotic delivery system targeted to probiotic bacteria |
| CN110013490A (en) * | 2018-01-09 | 2019-07-16 | 柯顺议 | Probiotic composition and application thereof |
| CN110279118A (en) * | 2019-06-14 | 2019-09-27 | 浙江大学宁波理工学院 | A kind of compound probiotic composition, compound probiotic freeze-dried powder capsule and preparation method |
| CN111084386A (en) * | 2020-02-28 | 2020-05-01 | 大连万众益生大健康有限公司 | Probiotic supplement with function of improving intestinal tract |
| CN111557448A (en) * | 2020-05-26 | 2020-08-21 | 深圳市东荣生物科技有限责任公司 | Compound microbial preparation for enhancing metabolic function of human body |
| CN111758830A (en) * | 2020-07-08 | 2020-10-13 | 天津蚓福生物科技开发有限公司 | Blood fat reducing antioxidant tabletting candy |
| CN113005067A (en) * | 2021-03-31 | 2021-06-22 | 盐城维康生物科技有限公司 | Multifunctional composite probiotic preparation and preparation method thereof |
| CN113491337A (en) * | 2021-06-15 | 2021-10-12 | 合生元（广州）健康产品有限公司 | Composition for regulating infant intestinal tract short-chain fatty acid metabolism and application thereof |
| CN113615838A (en) * | 2020-05-06 | 2021-11-09 | 宏浚实业有限公司 | Probiotic complexes for improving gastrointestinal health |
| CN114831286A (en) * | 2022-05-30 | 2022-08-02 | 天津小薇生物科技有限公司 | Composition with constipation relieving function and preparation method thereof |
| CN115054617A (en) * | 2022-07-07 | 2022-09-16 | 中国人民解放军陆军特色医学中心 | Probiotic composition for treating diarrhea-predominant irritable bowel syndrome and application thereof |
| CN115989836A (en) * | 2022-11-29 | 2023-04-21 | 黑龙江飞鹤乳业有限公司 | Nutritional composition containing lactoferrin and probiotics, food and application |
| WO2024055983A1 (en) * | 2022-09-14 | 2024-03-21 | 南京纽邦生物科技有限公司 | Composition of pumpkin seed protein and use thereof |
Citations (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN101323850A (en) * | 2008-07-28 | 2008-12-17 | 天津科技大学 | Lactobacillus helveticus microcapsule, preparation and use thereof |
| CN102341113A (en) * | 2009-01-12 | 2012-02-01 | 辉瑞意大利公司 | Compositions comprising probiotic and prebiotic components and mineral salts, with lactoferrin |
| CN104799392A (en) * | 2015-05-19 | 2015-07-29 | 河北金木药业集团有限公司 | Fruit-vegetable solid beverage with function of coordinating intestines and stomach and preparation method for fruit-vegetable solid beverage |
-
2017
- 2017-02-17 CN CN201710086798.XA patent/CN106820156A/en active Pending
Patent Citations (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN101323850A (en) * | 2008-07-28 | 2008-12-17 | 天津科技大学 | Lactobacillus helveticus microcapsule, preparation and use thereof |
| CN102341113A (en) * | 2009-01-12 | 2012-02-01 | 辉瑞意大利公司 | Compositions comprising probiotic and prebiotic components and mineral salts, with lactoferrin |
| CN104799392A (en) * | 2015-05-19 | 2015-07-29 | 河北金木药业集团有限公司 | Fruit-vegetable solid beverage with function of coordinating intestines and stomach and preparation method for fruit-vegetable solid beverage |
Non-Patent Citations (2)
| Title |
|---|
| 林奏延: "《华人育儿百科》", 30 November 2016, 北京联合出版公司 * |
| 海关总署关税征管司: "《进出口税则商品及品目注释：2012年版》", 28 February 2012, 中国海关出版社 * |
Cited By (21)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN107455744A (en) * | 2017-08-22 | 2017-12-12 | 绵阳市润土农业科技开发有限公司 | A kind of fementative composition ferment and preparation method thereof in vivo |
| WO2019049157A1 (en) * | 2017-09-10 | 2019-03-14 | Technion Research & Development Foundation Limited | Composition and method for a prebiotic delivery system targeted to probiotic bacteria |
| CN108208843A (en) * | 2017-12-30 | 2018-06-29 | 广州润虹医药科技股份有限公司 | A kind of health composition for adjusting intestinal flora and application thereof |
| CN110013490A (en) * | 2018-01-09 | 2019-07-16 | 柯顺议 | Probiotic composition and application thereof |
| CN109123679A (en) * | 2018-08-21 | 2019-01-04 | 卓源健康科技有限公司 | A kind of lactic bacteria composition and preparation method thereof with adjusting intestinal flora function |
| CN108936679A (en) * | 2018-08-29 | 2018-12-07 | 广东时代食品与生命健康研究有限公司 | A kind of compound intestinal health health care product |
| CN109432333A (en) * | 2018-10-11 | 2019-03-08 | 张军毅 | A kind of synbiotic compound preparation and preparation method thereof for helping to alleviate no solid lesion hypertension symptom |
| CN110279118A (en) * | 2019-06-14 | 2019-09-27 | 浙江大学宁波理工学院 | A kind of compound probiotic composition, compound probiotic freeze-dried powder capsule and preparation method |
| CN111084386A (en) * | 2020-02-28 | 2020-05-01 | 大连万众益生大健康有限公司 | Probiotic supplement with function of improving intestinal tract |
| CN113615838A (en) * | 2020-05-06 | 2021-11-09 | 宏浚实业有限公司 | Probiotic complexes for improving gastrointestinal health |
| CN111557448A (en) * | 2020-05-26 | 2020-08-21 | 深圳市东荣生物科技有限责任公司 | Compound microbial preparation for enhancing metabolic function of human body |
| CN111758830A (en) * | 2020-07-08 | 2020-10-13 | 天津蚓福生物科技开发有限公司 | Blood fat reducing antioxidant tabletting candy |
| CN111758830B (en) * | 2020-07-08 | 2022-03-29 | 天津蚓福生物科技开发有限公司 | Blood fat reducing antioxidant tabletting candy |
| CN113005067A (en) * | 2021-03-31 | 2021-06-22 | 盐城维康生物科技有限公司 | Multifunctional composite probiotic preparation and preparation method thereof |
| CN113491337A (en) * | 2021-06-15 | 2021-10-12 | 合生元（广州）健康产品有限公司 | Composition for regulating infant intestinal tract short-chain fatty acid metabolism and application thereof |
| CN114831286A (en) * | 2022-05-30 | 2022-08-02 | 天津小薇生物科技有限公司 | Composition with constipation relieving function and preparation method thereof |
| CN114831286B (en) * | 2022-05-30 | 2023-09-26 | 天津小薇生物科技有限公司 | Composition with constipation relieving function and preparation method thereof |
| CN115054617A (en) * | 2022-07-07 | 2022-09-16 | 中国人民解放军陆军特色医学中心 | Probiotic composition for treating diarrhea-predominant irritable bowel syndrome and application thereof |
| CN115054617B (en) * | 2022-07-07 | 2023-12-22 | 中国人民解放军陆军特色医学中心 | Probiotic composition for treating diarrhea type irritable bowel syndrome and application thereof |
| WO2024055983A1 (en) * | 2022-09-14 | 2024-03-21 | 南京纽邦生物科技有限公司 | Composition of pumpkin seed protein and use thereof |
| CN115989836A (en) * | 2022-11-29 | 2023-04-21 | 黑龙江飞鹤乳业有限公司 | Nutritional composition containing lactoferrin and probiotics, food and application |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN106820156A (en) | A kind of probiotic composition of regulating intestinal canal flora health | |
| CN111944725B (en) | Lactobacillus paracasei 207-27 and application thereof | |
| Kalantzopoulos | Fermented products with probiotic qualities | |
| CN111944727B (en) | Bifidobacterium breve 207-1 and application thereof | |
| CN101160134B (en) | Selection and use of lactic acid bacteria for reducing inflammation in mammals | |
| CN110892935A (en) | Bifidobacterium lactis for treating constipation and diarrhea and application thereof | |
| RU2009149393A (en) | MICRO-ORGANISMS OF MILK-LIVING MILK, THEIR CONTAINING COMPOSITIONS AND THEIR APPLICATION FOR TREATMENT OF MASTITIS | |
| JP2005508150A (en) | Probiotic Lactobacillus casei strains | |
| CN107095292A (en) | It is a kind of that there is plant composite enzyme of regulation gut flora function and preparation method thereof | |
| TWI739495B (en) | Composition for promoting defecation and use therefor | |
| CN111548972A (en) | Lactobacillus plantarum with helicobacter pylori resistance function and application thereof | |
| Vemuri et al. | Probiotics: a novel approach in improving the values of human life | |
| El Sayed et al. | Encapsulation of probiotics using mixed sodium alginate and rice flour to enhance their survivability in simulated gastric conditions and in UF-Kariesh cheese | |
| CN107949633A (en) | Novel lactobacillus species microorganism and the composition for animal feed for including it | |
| CN105559087A (en) | Probiotic product containing sialic acid and preparation method of probiotic product | |
| Maity et al. | Development of healthy whey drink with Lactobacillus rhamnosus, Bifidobacterium bifidum and Propionibacterium freudenreichii subsp. shermanii | |
| Samedi et al. | Evaluation of technological and probiotic abilities of local lactic acid bacteria | |
| CN116555076B (en) | Bifidobacterium longum subspecies longum MY1 and application thereof in preparation of food and medicine for relaxing bowels and protecting intestines | |
| MXPA05010696A (en) | Lactobacillus fermentum strain and uses thereof. | |
| Ray | Probiotics of lactic acid bacteria: science or myth? | |
| Sherwani | Probiotics in processed dairy products and their role in gut microbiota health | |
| CN111296842B (en) | Probiotic composition with anti-allergy effect | |
| CN117106628B (en) | Lactobacillus acidophilus LA15 with immunoregulation capability and application, product and method thereof | |
| Rogelj | Lactic acid bacteria as probiotics | |
| CN117070398B (en) | Bifidobacterium animalis subspecies Bi66 for improving constipation and application, product and method thereof |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PB01 | Publication | ||
| PB01 | Publication | ||
| SE01 | Entry into force of request for substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| RJ01 | Rejection of invention patent application after publication |
Application publication date: 20170613 |
|
| RJ01 | Rejection of invention patent application after publication |